Poland· PL-100451841

HEVASCOL

A ethylester von iodierten fettsäuren product containing oleum ethiodatum, registered in Poland by Guerbet. The same ATC class is registered in 9 of our 19 countries.

ATC V08AD01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHEVASCOLATCV08AD01REGISTER NO.PL-100451841PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Ethylester von iodierten fettsäuren is registered in 9 of 19 countries.

Countries holding a registration under ATC V08AD01 (ethylester von iodierten fettsäuren), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Ethylester von iodierten fettsäuren · ATC V08AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Oleum ethiodatum
Manufacturer
Guerbet
Country
Poland (PL)
ATC code
V08AD01
ATC class
Ethylester von iodierten Fettsäuren
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991500122

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for ethylester von iodierten fettsäuren.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ethylester von iodierten fettsäuren · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • AldesleukinL03AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eeb49a8d-a77b-4953-81a9-1efc4557289f
GET /v1/drugs/eeb49a8d-a77b-4953-81a9-1efc4557289f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "480 mg I/ml",
  "packaging": "05909991500122 ¦ Rp ¦ 147499\n1 amp. 10 ml",
  "substance": "Oleum ethiodatum 1280 mg/ml (co odpowiada 480 mg jodu/ml)",
  "common_name": "Oleum ethiodatum",
  "pl_product_id": "100451841",
  "pozwolenie_nr": "27445",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-11-04"
}

See everything about ethylester von iodierten fettsäuren.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.